Stockreport

Repare Therapeutics cuts quarter of its workforce and prioritises clinical assets [Yahoo! Finance]

Repare Therapeutics Inc. - Common Shares  (RPTX) 
PDF The Canadian biotech, which posted a net loss of $34.8m in Q2 financial results earlier this month, said it would focus on the advancement of lunresertib and camonserti [Read more]